APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: The Chronic Hepatitis Cohort Study (CHeCS)

Journal of Viral Hepatitis

Volumn 21, Issue 12, 2014, Pages 917-920

  Teshale, E ^a   Lu, M ^b   Rupp, L B ^b   Holmberg, S D ^a   Moorman, A C ^a   Spradling, P ^a   Vijayadeva, V ^c   Boscarino, J A ^d   Schmidt, M A ^c   Gordon, S C ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c CENTER FOR HEALTH RESEARCH   (United States)

^d GEISINGER HEALTH SYSTEM   (United States)

Author keywords

APRI; AST ALT ratio; chronic hepatitis B; FIB 4; liver fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYTICAL PARAMETERS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FIBROSIS 4 SCORE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; SCORING SYSTEM; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; STAGING; BLOOD; COMPLICATION; EVALUATION STUDY; HEPATITIS B, CHRONIC; LIVER CIRRHOSIS; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; THROMBOCYTE COUNT;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84911417990     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12279     Document Type: Article

References (8)

1. Lok AS, McMahon BJ,. Hepatitis B guidelines, update 2009. Hepatology 2009; 50 (3): 661-662.
2. Bravo AA, Sheth SG, Chopra S,. Liver biopsy. N Engl J Med 2001; 344: 495-500.
3. Moorman AC, Gordon SC, Rupp LB, et al,. Baseline characteristics and mortality among people in care for chronic viral hepatitis: the Chronic Hepatitis Cohort Study ('CHeCS'). Clin Infect Dis 2013; 11: 303-308.
4. Wiersma S, McMahon B, Pawlotsky JM, et al,. Treatment of chronic hepatitis B infection in resource constrained settings: expert panel consensus. Liver Int 2011; 31 (6): 755-761.
5. Holmberg S, Lu M, Rupp L, et al,. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort. Clin Infect Dis 2013; 57 (2): 240-6.
6. Chon YE, Jung ES, Park JY, et al,. The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B. J Clin Gastroenterol 2012; 46: 518-525.
7. Jin W, Lin Z, Xin Y, Jiang X, Dong Q, Xuan S,. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol 2012; 12: 14.
8. Zhou K, Gao C, Zhao Y, et al,. Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B. J Gastroenterol Hepatol 2010; 25 (9): 1569-1577.